Do CYP2D6 genotypes affect oxycodone dose, pharmacokinetics, pain, and adverse effects in cancer?
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Genetic variations in CYP2D6 did not impact oxycodone response in advanced cancer patients. However, higher levels of oxycodone metabolites, noroxycodone and oxymorphone, were linked to uncontrolled pain.
Area Of Science
- Pharmacogenomics
- Oncology
- Pain Management
Background
- Oxycodone is a widely used opioid for cancer pain.
- CYP2D6 and CYP3A4 enzymes metabolize oxycodone.
- Genetic polymorphisms in these enzymes may affect treatment efficacy and safety.
Purpose Of The Study
- To investigate the relationship between CYP2D6 and CYP3A4 genetic variations, oxycodone and metabolite plasma concentrations, and patient response.
- To assess the impact on pain scores, dosage, and adverse effects in advanced cancer patients.
Main Methods
- Multi-center prospective cohort study.
- Inclusion of clinical data, pain/adverse effect questionnaires, and biological samples (blood for pharmacokinetics and DNA).
- Statistical analysis using negative binomial and logistic regression.
Main Results
- No significant differences in oxycodone response were observed between CYP2D6 intermediate/poor metabolizers and normal metabolizers.
- Higher plasma concentrations of noroxycodone and increased noroxycodone/oxycodone ratios were associated with a higher likelihood of uncontrolled average pain (OR 2.44 and 10.48, respectively).
- The study included 33 participants.
Conclusions
- CYP2D6 genotyping did not demonstrate a clear benefit in predicting oxycodone response.
- Monitoring plasma concentrations of oxycodone metabolites, specifically noroxycodone and oxymorphone, warrants further investigation for managing cancer pain.
- This suggests a potential role for metabolite monitoring over genetic profiling in this patient population.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...